3[73]Potocnik U,Ferkolj I,Glavac D,Dean M.Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.Genes Immun 2004; 5:530-539
4[74]Palmieri O,Latiano A,Valvano R,D'Inca R,Vecchi M,Sturniolo GC,Saibeni S,Bossa F,Latiano T,Devoto M,Andriulli A,Annese V.Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.Aliment Pharmacol Ther 2005; 22:1129-1138
5[75]Urcelay E,Mendoza JL,Martin MC,Mas A,Martinez A,Taxonera C,Fernandez-Arquero M,Diaz-Rubio M,de la Concha EG.MDR1 gene:susceptibility in Spanish Crohn's disease and ulcerative colitis patients.Inflamm Bowel Dis 2006; 12:33-37
6[76]Farrell RJ,Murphy A,Long A,Dormelly S,Cherikuri A,O'Toole D,Mahmud N,Keeling PW,Weir DG,Kelleher D.High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.Gastroenterology 2000; 118:279-288
7[77]McGovern DP,Ahmad T,Van Heel D,Negoro K,Jewell D.Cytochrome p450 and multidrug-resistance gene 1 (MDR-1)polymorphisms:predictors of the need for colectomy in ulcerative colitis? Gastroenterology 2002; 122:W1313
8[78]Yacyshyn B,Maksymowych W,Bowen-Yacyshyn MB.Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.Hum Immunol 1999; 60:677-687
9[79]Langmann T,Moehle C,Mauerer R,Scharl M,Liebisch G,Zahn A,Stremmel W,Schmitz G.Loss of detoxification in inflammatory bowel disease:dysregulation of pregnane X receptor target genes.Gastroenterology 2004; 127:26-40
10[1]Schinkel AH.The physiological function of drug-transporting P-glycoproteins.Semin Cancer Biol 1997; 8:161-170
5Chen CJ, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdrl (P glycoprotein) gene from multidrug-resistant human cells. Ce11,1986,47:381-389.
6Krupoves A, Mack D, Seidman E, et al. Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn:s disease. Inflamm Bowel Dis, 2011,17 : 2308 2317.
7Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glyeoprotein expression and activity in vivo. Proe Natl Acad Sci U S A,2000,97:3473-3478.
8Bonhomme-Faivre L, Devocelle A, Saliba F, et al. MDR-1 C3435T poIymorplaism influences cyelosporine a dose requirement in liver-transplant recipients. Transplantation, 2004,78 : 21-25.
9Goh BC, Lee SC, Wang LZ, et al. Explaining interindividual variability of doeetaxel pharmacokinetics andpharmacodynamics in Asians through phenotyping and genotyping strategies. J Clin Oncol, 2002,20 : 3683-3690.
10Zhang X, Liu ZH, Zheng JM,et al. Influence of CYP3A5 and MDR1 polymorphisms on tacroIimus concentration in the early stage after renal transplantation. Clin Transplant, 2005, 19:638-643.
